Everolimus tablets 10 mg, 28 tablets (each carton contains 4 blister strips with 7 tablets each), Rx only, Manufactured by: Par Pharmaceutical Chestnut Ridge, NY 10977 NDC# 49884-128-91
Published November 5, 2025 · Recall initiated: October 10, 2025
Summary
FDA records drug Class III recall D-0141-2026, published November 5, 2025 and initiated October 10, 2025. Recalling firm: Endo USA, Inc.; Status: Ongoing; Reported quantity: 935 cartons; Lot: Lot #: 550162801, Exp. Date NOV-25; 550169801, Exp. Date JAN-26. Class III means the product is not likely to cause adverse health consequences.
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Failed Impurities/Degradation Specifications: Out of specification for impurity IP-C.
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Endo USA, Inc.
- Distributor
- Nationwide within the United States
- Lot
- Lot #: 550162801, Exp. Date NOV-25; 550169801, Exp. Date JAN-26
- Risk classification
- Class III
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAEverolimus tablets 7.5mg, 28 tablets (each carton contains 4 blister strips with 7 tablets each), Rx only,November 5, 2025
- FDAEverolimus tablets 2.5 mg, 28 tablets (each carton contains 4 blister strips with 7 tablets each), Rx only,November 5, 2025
- FDAEverolimus tablets 5mg, 28 tablets (each carton contains 4 blister strips with 7 tablets each), Rx only,November 5, 2025
- FDA0.9% SODIUM CHLORIDE Injection, USP, 100 mL, Rx only, ICU Medical, Inc., Lake Forest, Illinois, 60045, USA,November 5, 2025
- FDAEspumil, Lipophilic foam base, 500 ml, 24G15-T02-115604November 5, 2025
- FDAEverolimus tablets 5mg, 28 tablets (each carton contains 4 blister strips with 7 tablets each), Rx only,October 22, 2025
Questions about this recall
Was Everolimus tablets 10 mg, 28 tablets (each carton contains 4 blister strips with 7 tablets each), Rx only, Manufactured by: Par Pharmaceutical Chestnut Ridge, NY 10977 NDC# 49884-128-91 recalled?
Yes. FDA published recall D-0141-2026 on November 5, 2025. Reported hazard: Failed Impurities/Degradation Specifications: Out of specification for impurity IP-C.
What should I do if I have this product?
Voluntary: Firm initiated · Letter